What is MHealth App Market?
MHealth (mobile health) is a broad term for the use of mobile phones and other wireless technology in medical care. The most common application of MHealth is the use of mobile devices to educate consumers about preventive healthcare services. However, MHealth is also used for disease surveillance, treatment support, epidemic outbreak tracking, and chronic disease management. Owing to the low density of physicians, the demand for MHealth application has surged across the globe. The penetration of smartphones across the globe is one of the major reason to use the MHealth application on consumers end.
The market study is being classified by Type (Fitness, Disease Management, Women's Health, Lifestyle Management, Nutrition & Diet, Healthcare Providers/ Payors, Medication Adherence and Others) and major geographies with country level break-up. According to AMA, the Global MHealth App market is expected to see growth rate of 42.2%
Omron Corporation (Japan), Airstrip Technologies, Inc. (United States), Diversinet Corp. (Canada), Philips Healthcare (Netherland), Qualcomm (United States), Johnson and Johnson (United States), AstraZeneca PLC (United Kingdom), Roche (Switzerland), Novartis (Switzerland), Bristol-Myers Squibb (United States), GlaxoSmithKline PLC (United Kingdom), Pfizer (United States) and Sanofi (France) are some of the key players profiled in the study. Additionally, the Players which are also part of the research are Hoffmann-La Roche AG (Switzerland) and Merck and Co. (United States).
Research Analyst at AMA predicts that United States and Switzerland Players will contribute to the maximum growth of Global MHealth App market throughout the predicted period.
Analyst at AMA have segmented the market study of Global MHealth App market by Type, Application and Region.
On the basis of geography, the market of MHealth App has been segmented into South America (Brazil, Argentina, Rest of South America), Asia Pacific (China, Japan, India, South Korea, Taiwan, Australia, Rest of Asia-Pacific), Europe (Germany, France, Italy, United Kingdom, Netherlands, Rest of Europe), MEA (Middle East, Africa), North America (United States, Canada, Mexico). Additionally, the rising demand from SMEs and various industry verticals gives enough cushion to market growth.
- Increasing Penetration of Smartphones, Tablets, and Other Mobile Platforms
- Increasing Utilization of Connected Devices and mHealth Apps for the Management of Chronic Diseases
- Cost Containment in Healthcare Delivery
- Robust Penetration of 3G and 4G Networks for Uninterrupted Healthcare Services
- Rising Focus on Patient-Centric Healthcare Delivery
- Lack of Standards and Regulations as Well as Paucity of Reimbursements
- Low Guidance from Physicians in Selecting Apps
- Resistance from Traditional Healthcare Providers
- Increasing Incidence of Lifestyle Disorders
- Low Physician Density Creates Platforms for Greater Adoption of mHealth Apps in Developing Countries
- Difficulties in finding mHealth Apps on Android or Apple Stores
- Patent Protection for mHealth Devices and Applications
- Lack of Data Security Giving Rise to Concerns Regarding Data Theft and Healthcare Fraud
On 27 April 2018, Novartis has launched FocalView app, an ophthalmic digital research platform created with ResearchKit. This app is designed to collect data directly from patients in order to track disease protection and allow them to participate in ophthalmology clinical trials from home.
Key Target AudienceHealthcare application developers, Medical device vendors, Mobile network providers, Connectivity providers, Mobile platform developers, Insurance providers (payers), Healthcare institutions (hospitals, medical schools, and outpatient clinics), Research and consulting firms, Research institutes, Contract research organizations (CROs), Contract manufacturing organizations (CMOs) and Venture capitalists